Chronic Systolic Heart Failure: Symptoms, Causes & Treatment

Table of Contents

Climbing one flight of stairs should not leave you breathless. Your ankles should not be swollen by the end of the day. Feeling worn out after a short walk is not a normal part of aging.

These are warning signs that your heart is not pumping blood the way it should. The condition behind them is called chronic systolic heart failure. It is a long-term condition where the heart’s main pumping chamber has become too weak to do its job properly.

If you have just been told you have this condition this article gives you straight answers. What causes it. What symptoms to expect. What treatment involves. And what the research says about living with it.

What Is Chronic Systolic Heart Failure? (Quick Answer)

Chronic systolic heart failure means the heart’s main pumping chamber — the left ventricle — has lost the muscle strength to push enough blood out to the body. Doctors measure this pumping strength as a percentage called ejection fraction (EF). A healthy heart pumps out 55–70% of its blood with each beat. In chronic systolic heart failure, that number falls below 40% — and sometimes as low as 15–20% in severe cases. The body’s organs stop getting enough oxygen-rich blood, and symptoms follow. You will also see this condition called HFrEF — Heart Failure with Reduced Ejection Fraction. It means the same thing.

What Is Chronic Systolic Heart Failure?

With every heartbeat, the left ventricle squeezes and pushes blood out to the rest of the body. A healthy heart pushes out 55–70% of the blood it holds. In chronic systolic heart failure, the muscle has weakened to the point where it can only push out less than 40% per beat.

This pumping percentage is called the ejection fraction (EF). It is measured by a heart ultrasound called echocardiogram.

An EF below 40%, combined with symptoms, confirms this diagnosis. You may also see it written as HFrEF in your records.

Systolic vs. Diastolic Heart Failure — why the difference matters: Diastolic heart failure (HFpEF) is a different condition where the heart squeezes normally but the muscle has stiffened and cannot fill properly between beats. In systolic heart failure, the squeeze itself is the problem — the muscle is too weak. The two conditions need different treatments. Drugs that save lives in systolic heart failure do not have the same proven benefit in diastolic heart failure.

“Chronic” means this is an ongoing condition that develops slowly and needs long-term management — it does not resolve on its own.

What Causes Chronic Systolic Heart Failure?

The heart muscle does not weaken without a reason. In most cases, one of the following is responsible:

Blocked Heart Arteries (Coronary Artery Disease)

The most common cause. A fatty buildup called plaque gradually narrows the arteries that supply blood to the heart muscle. Over years, the muscle is starved of oxygen and slowly weakens. This is the same process behind most heart attacks.

A Previous Heart Attack

A heart attack kills a section of heart muscle. That dead tissue turns into scar tissue — and scar tissue cannot contract. The larger the scarred area, the weaker the pump. Many patients do not realize the damage keeps developing after the event itself. Many people develop systolic heart failure 6–18 months after a heart attack they believed they had fully recovered from.

Dilated Cardiomyopathy (Enlarged, Weakened Heart)

This is a disease of the heart muscle itself. The left ventricle stretches and its walls thin out, making it a poor pump. It can be inherited, triggered by years of heavy alcohol use, caused by a viral infection that inflamed the heart muscle.

Long-Term High Blood Pressure

When blood pressure stays high for years, the heart works harder with every beat. At first, the heart muscle thickens to cope — like any muscle under strain. But it cannot keep up, the chamber stretches, and the pump weakens. This shift from high blood pressure to heart failure can take decades.

Damaged Heart Valves

Heart valves keep blood flowing in one direction. When a valve leaks backward and blocks flow, the heart must work hard to compensate. Left untreated long enough, that extra strain weakens the pump.

Less Common Causes

Chemotherapy drugs — particularly doxorubicin and trastuzumab — can damage heart muscle cells as a side effect
Viral infections that inflame the heart muscle, including COVID-19-related myocarditis
Chronic heavy alcohol use — alcohol is directly toxic to heart muscle cells
Thyroid disorders — both an overactive and underactive thyroid can affect how the heart contracts
A persistently fast heart rate — such as uncontrolled atrial fibrillation — can weaken the heart muscle over time

Symptoms of Chronic Systolic Heart Failure

Symptoms come from two things happening at the same time. First, the heart is not pushing enough blood forward to meet the body’s needs. Second, blood backs up behind the failing pump, causing fluid to build up in the lungs and body tissues. Both usually happen together.

Shortness of Breath

This is the most common symptom. It starts during physical activity — climbing stairs, walking fast — and as the condition worsens, it can happen with little effort. Two patterns are important to know:

Breathlessness when lying flat: Many patients find they need to sleep propped up on two pillows. When you lie down, fluid that was pooling in the legs shifts up to the lungs.
Waking up gasping: Some patients wake suddenly 1–2 hours after falling asleep struggling to breathe. This happens for the same reason — fluid builds up in the lungs after lying still long enough.

Tiredness and Weakness

When muscles and organs are not getting enough oxygen-rich blood, deep tiredness sets in. This is not ordinary fatigue — it is a direct result of the heart not keeping up with what the body needs. Tasks that used to feel easy become draining.

Swollen Legs and Ankles

When the kidneys sense low blood flow, they hold onto salt and water. That retained fluid pools in the lower legs, ankles, and feet — usually worse by the end of the day. Pressing a finger into the swollen area leaves a dent that fills back in slowly.

Fast Heartbeat

The heart speeds up to try to compensate for its weak pumping. This makes things worse over time. Additionally, roughly 40% of people with systolic heart failure develop atrial fibrillation — an irregular rhythm where the upper chambers of the heart quiver instead of squeezing properly. Atrial fibrillation makes heart failure symptoms worse and significantly raises the risk of stroke.

Persistent Cough

Fluid backing up into the lungs irritates the airways and causes a chronic dry cough. It is often mistaken for asthma. The key difference: this cough improves when fluid is removed with medication — it does not get better with inhalers.

Abdominal Fullness and Nausea

When fluid congestion extends to the right side of the heart, the liver becomes enlarged and tender. This causes discomfort in the upper abdomen, a feeling of fullness after small meals, and sometimes nausea. In severe cases, fluid collects in the abdominal cavity.

Go to the Emergency Room Immediately If You Experience:

Sudden severe shortness of breath at rest — especially if it came on quickly

Coughing up foamy fluid — this signals fluid in the lungs

Chest pain

Fainting or near-fainting

Weight gain of 2 or more pounds in a single day

New confusion or inability to finish a sentence because of breathlessness

4. How Is Chronic Systolic Heart Failure Diagnosed?

Echocardiogram — The Key Test

A technician uses an ultrasound probe on the chest to create a live image of the heart beating. It measures ejection fraction, checks how well the heart wall moves, and evaluates the valves. An EF below 40% on this test confirms systolic heart failure. If image quality is poor, a cardiac MRI is ordered instead.

Blood Tests — BNP and NT-proBNP

When the heart is under stress from fluid overload, it releases markers into the bloodstream. NT-proBNP above 300 pg/mL points toward heart failure. These same tests are used later to check whether treatment is working — falling NT-proBNP levels during treatment mean the heart is getting less congested.

Chest X-Ray

A chest X-ray can show an enlarged heart, fluid in the lung tissue, and congested blood vessels. It does not confirm heart failure on its own but provides useful supporting information.

ECG (Heart Tracing)

An ECG records the heart’s electrical activity. It can reveal evidence of a previous heart attack, a conduction problem called left bundle branch block, atrial fibrillation, and other abnormalities.

Additional Tests When Needed

Coronary angiography — a dye test that maps the heart arteries and shows whether blockages are the cause of heart failure
Cardiopulmonary exercise test (CPET) — measures how well the heart and lungs work during exercise; produces a number used in transplant eligibility decisions
Right heart catheterization — a thin tube guided to the right side of the heart to measure pressure directly; used when planning advanced therapies

Understanding Your Heart Failure Stage and Class

Doctors use two classification systems. Knowing both helps you understand what your care team is tracking:

ACC/AHA Stage	NYHA Class	What It Means	What Your Care Team Focuses On
Stage A	—	You have risk factors (high blood pressure, diabetes) but no heart damage and no symptoms yet	Preventing heart failure — control blood pressure, blood sugar, cholesterol
Stage B	Class I	Heart damage is present but you have no symptoms yet	Starting medications that slow further damage
Stage C	Class I–III	You have heart damage and have had symptoms	Full medical treatment — all four drug classes plus devices if needed
Stage D	Class IV	Severe symptoms despite maximum treatment	Advanced options: mechanical heart pump (LVAD), transplant evaluation, or comfort-focused care

Important: The ACC/AHA stages only move forward. Once you are at Stage C, you stay at Stage C — even if treatment brings symptoms fully under control. The NYHA class reflects how you feel right now and can improve with treatment.

5. Treatment: The Four Core Drug Classes

Since 2021, the ACC/AHA guidelines say that every patient with an ejection fraction of 40% should be on four specific drug classes — unless a medical reason prevents it. These are called Guideline-Directed Medical Therapy. Together, the evidence shows they cut the risk of death by roughly 50% compared to placebo.

Drug Class	Examples	What It Does	Side Effects to Know
ARNI — preferred first choice (or ACE inhibitor / ARB if ARNI not tolerated)	Sacubitril/valsartan (Entresto); Ramipril, Lisinopril; Losartan	Relaxes blood vessels so the heart pumps against less resistance. Also blocks hormones that cause the heart muscle to stiffen and scar over time.	Low blood pressure, high potassium, dry cough (ACE inhibitors), rare throat swelling
Beta-blocker (only 3 specific ones are proven)	Carvedilol; Metoprolol succinate; Bisoprolol	Slows the heart rate and reduces how hard the heart works. Over months, the heart muscle often partially recovers because it is no longer under constant strain.	Fatigue, dizziness, slow pulse. Must be started at a low dose and increased gradually
MRA (mineralocorticoid receptor antagonist)	Spironolactone; Eplerenone	Blocks a hormone called aldosterone that causes the heart muscle to scar and the body to retain fluid.	High potassium (requires blood test monitoring), breast tenderness in men with spironolactone
SGLT2 inhibitor (originally a diabetes drug — proven to work regardless of diabetes status)	Empagliflozin (Jardiance); Dapagliflozin (Farxiga)	Makes the kidneys remove excess fluid through urine, reducing the load on the heart. Also has direct protective effects on heart muscle cells.	Genital yeast infections, increased urination. Rare: a serious condition called euglycemic DKA

Two critical points: First, only three beta-blockers are proven to reduce death in this condition — carvedilol, metoprolol succinate, and bisoprolol. Other beta-blockers must not be substituted. Second, sacubitril/valsartan (Entresto) is now the preferred first choice over older ACE inhibitors. The PARADIGM-HF trial showed it cut cardiovascular deaths by a further 20% compared to enalapril, which was already the standard treatment.

Water Pills (Diuretics) — For Symptom Relief

Diuretics — furosemide, torsemide, bumetanide — are not part of the four survival-improving drug classes, but they are essential for removing the excess fluid that causes breathlessness and swelling. They work by making the kidneys produce more urine. The dose is adjusted until you reach your “dry weight” — the weight at which your body holds no extra fluid. Torsemide is increasingly preferred over furosemide because the gut absorbs it more reliably.

Implanted Devices

ICD (Implantable Cardioverter-Defibrillator): A small device placed under the skin near the shoulder, connected by wires to the heart. It monitors heart rhythm around the clock and delivers an automatic shock if a life-threatening rhythm develops. Recommended for patients with EF ≤ 35% who have been on maximum medications for at least 3 months — that waiting period exists because medications often improve EF enough that the device is no longer needed.

CRT (Cardiac Resynchronization Therapy): In some patients, the left and right sides of the heart beat out of step with each other because of an electrical problem called left bundle branch block. This makes the pump even less efficient — like rowing a boat with the oars out of rhythm. CRT uses a specialized pacemaker to coordinate both sides at the same time. It improves ejection fraction by an average of 5–10 percentage points and reduces hospitalizations. It is used when EF ≤ 35%, LBBB is present, and the electrical delay (QRS duration) is 150 milliseconds or more. Many devices combine CRT with an ICD in one unit (CRT-D).

Options for Advanced (Stage D) Heart Failure

LVAD (Left Ventricular Assist Device): A mechanical pump placed surgically inside the chest to help the left ventricle move blood. The most advanced current device, the HeartMate 3, achieves 2-year survival of about 77% in carefully selected patients. Used as a bridge while waiting for a transplant, or as a permanent solution for patients who are not transplant candidates.

Heart Transplant: The definitive treatment for end-stage heart failure. Over 85% of recipients are alive at one year; median survival is 12–13 years. To qualify, patients must have no active cancer, no irreversible high lung pressure, no severe obesity, and no active alcohol use. The main limiting factor is donor heart availability — typical waiting times are 3–6 months in the US, depending on blood type and transplant center.

Remote Monitoring

The CardioMEMS device is a small sensor placed inside the blood vessel leading from the heart to the lungs. It sends daily pressure readings to the care team. When pressure rises, the team can adjust diuretic doses before symptoms worsen. The CHAMPION trial found this cut heart failure hospitalizations by 37%. Bluetooth-connected scales that send daily weight data to the clinic work in a similar way.

6. Conditions That Occur Alongside Heart Failure

Most people with chronic systolic heart failure have at least one other ongoing health condition. These are not separate problems — they directly affect which drugs are safe, what doses are appropriate, and what the outlook looks like.

Condition	How Common in HFrEF	What Changes in Management
Atrial Fibrillation (irregular heart rhythm)	~40%	Beta-blockers control the heart rate. Blood thinners prevent stroke. In some patients, a procedure called catheter ablation to restore normal rhythm has been shown to reduce deaths in heart failure — from a trial called CASTLE-AF.
Chronic Kidney Disease (reduced kidney function)	~50%	Kidney disease limits how high the dose of ACE inhibitors, ARBs, and spironolactone can be pushed, because these drugs raise potassium and weakened kidneys clear it poorly. SGLT2 inhibitors are valuable here — they protect the kidneys and the heart at the same time.
Type 2 Diabetes	~35%	SGLT2 inhibitors (Jardiance, Farxiga) are the preferred diabetes drug in heart failure — they treat both conditions at once. Two diabetes drugs to avoid: thiazolidinediones (like pioglitazone) cause fluid retention, and saxagliptin increases heart failure hospitalizations.
Iron Deficiency	~50%	Iron deficiency is common in heart failure even without obvious anaemia. Iron given by IV infusion (ferric carboxymaltose) improves exercise capacity and reduces hospitalizations — proven in the AFFIRM-AHF trial. Iron tablets work poorly here.
Sleep Apnea	30–50%	Obstructive sleep apnea (airway blocks during sleep) is treated with CPAP, which improves symptoms. Central sleep apnea (the brain fails to trigger breathing normally) is different. The ventilator type called adaptive servo-ventilation (ASV) must NOT be used in heart failure patients with EF below 45% — the SERVE-HF trial showed it increased deaths.
Depression	~30%	Depression triples the risk of death in heart failure, independent of disease severity. SSRI antidepressants (sertraline, escitalopram) are safe. Older tricyclic antidepressants must be avoided — they cause dangerous heart rhythms. Cardiac rehabilitation also has a proven antidepressant effect in this group.

7. Lifestyle Changes That Make a Real Difference

Keep Sodium Below 2,000 mg Per Day

Sodium causes the body to hold onto water. Extra fluid makes the lungs and body more congested and makes every symptom worse. The target is under 2,000 mg of sodium per day — roughly one teaspoon of table salt. The challenge is that 70% of the sodium in a typical diet comes from processed and restaurant food, not from anything added at the table.

High-Sodium Foods to Cut Back On

Canned soups and broths — 600–1,200 mg per serving. Choose low-sodium versions.

Deli and cured meats — 400–900 mg per 2 oz serving

Bread and rolls — 100–230 mg per slice. An easy source to miss because most people eat several slices a day.

Pizza — 600–1,200 mg per slice

Condiments — pickles, soy sauce, ketchup: 200–900 mg per tablespoon

Frozen ready meals — often 800–1,500 mg per package

Restaurant main courses — frequently 1,500–3,000 mg in a single dish

Weigh Yourself Every Morning

Use the same scale every day — after your first trip to the bathroom, before eating or drinking. A gain of 2 or more pounds in 24 hours, or 5 or more pounds in one week, means fluid is building up faster than your medications can clear it. Call your care team the same day — your diuretic dose likely needs adjusting. This one habit alone prevents a large proportion of hospital admissions.

Limit Total Fluid Intake

When fluid is hard to control, most doctors recommend keeping total daily fluid to 1.5–2 liters — including water, juice, tea, coffee, soup, and liquid-rich foods like ice cream. This limit matters most when symptoms are getting worse.

Exercise — the Right Kind

Staying in bed is not recommended for stable heart failure patients. The HF-ACTION trial (2,331 patients) showed that structured aerobic exercise reduces hospitalizations and improves the body’s ability to use oxygen during exertion. Cardiac rehabilitation programs — supervised sessions tailored to your capacity — are the safest and most effective format. Walking and light cycling suit most stable patients. Heavy weightlifting is avoided because of the sudden pressure spikes it creates in the heart.

Take Medications Consistently

Stopping beta-blockers suddenly causes the heart rate to spike. Missing diuretics causes fluid to accumulate quickly. Non-adherence is the most common preventable reason people with heart failure end up in hospital. Tools that help: once-daily formulations, a weekly pill organizer, and pharmacy blister packs — each of these improves adherence by 10–20%.

8. Follow-Up Schedule and When to Seek Help

Managing heart failure is an active, ongoing process. The following schedule reflects standard practice at heart failure centers:

When	What Happens
1–2 weeks after leaving hospital or changing a medication	Symptom check, weight review, blood pressure check. Blood tests for potassium and kidney function — especially important after starting or adjusting diuretics or spironolactone.
Every 3–6 months (stable patients)	Review how much symptoms limit daily activity. Repeat BNP or NT-proBNP test. Increase medication doses if current doses are being tolerated well. Check medication adherence.
Every 6–12 months	Repeat echocardiogram to track whether EF has improved, stayed stable, or declined. Review ICD/CRT device eligibility. Check device settings if one is implanted.
Ongoing between visits	Remote monitoring data review (CardioMEMS or connected scale). Telehealth check-ins at most centers.

Call Your Doctor the Same Day If:

You gain 2 or more pounds overnight

Your ankles are more swollen than usual and raising your legs is not helping

Activities that felt manageable last week are now making you breathless

Your resting heart rate is consistently above 100 or below 50 beats per minute

You feel dizzy when you stand up — this can mean the diuretic dose is too high

Go to the ER — Do Not Wait:

Sudden severe breathlessness at rest

Chest pain or pressure

Coughing up pink or foamy fluid

Fainting

New confusion, or you cannot finish a sentence because of breathlessness

9. Life Expectancy and Prognosis

You may have seen statistics suggesting that roughly 50% of people with heart failure die within 5 years of diagnosis. That number is real but needs context. It comes from older studies covering all types and severities of heart failure — many from before SGLT2 inhibitors and sacubitril/valsartan became standard. Outcomes for patients on all four drug classes today are meaningfully better.

One of the most important and underreported findings in modern cardiology is that the heart can partially recover. This is called HFrecEF — Heart Failure with Recovered Ejection Fraction. In patients whose heart failure was not caused by a heart attack — particularly those with dilated cardiomyopathy — the ejection fraction returns to normal in approximately 30–40% of cases when all four drug classes are fully prescribed. These patients have substantially better long-term survival. The medications must continue indefinitely — stopping them frequently causes the EF to fall again.

Factors linked to a better outlook:

The cause was not a heart attack — scar tissue does not recover the way living muscle can
EF was above 30% at diagnosis
Symptoms were caught and treated early
All four drug classes were started and doses reached the recommended targets
No significant kidney disease or uncontrolled atrial fibrillation
Regular attendance at a cardiac rehabilitation program
No dangerous heart rhythms

10. Frequently Asked Questions

Is chronic systolic heart failure the same as congestive heart failure?

Not exactly. Congestive heart failure is an older umbrella term used when heart failure causes fluid congestion in the lungs or body. Chronic systolic heart failure is a specific subtype — defined by a weakened squeeze and reduced ejection fraction — that accounts for roughly half of all heart failure cases. The other main type is diastolic heart failure (HFpEF), where the squeeze is normal but the muscle is stiff.

What is a dangerous ejection fraction level?

An EF below 35% triggers consideration for an ICD because the risk of a sudden fatal heart rhythm is significantly elevated. An EF below 20–25% is considered severely reduced and signals high risk for sudden cardiac death, dangerous rhythms, and rapid decline. That said, EF alone does not tell the full story — some patients with very low EF are stable on strong medications, while others with EF closer to 40% are far more symptomatic. Clinical context always matters.

Is systolic heart failure worse than diastolic heart failure?

On average, HFrEF carries higher short-term mortality than HFpEF. However, HFpEF — more common in older adults and women — is harder to treat because no drug class has shown consistent survival benefit for it. Both conditions are serious. Comparing them matters less than getting the right treatment for whichever type a person has.

What happens if chronic systolic heart failure goes untreated?

Without treatment, the left ventricle progressively stretches and its walls thin — a process called adverse cardiac remodeling. As ejection fraction falls, the kidneys retain more and more salt and water, which worsens congestion, which strains the heart further. The heart beats faster to compensate, which damages the muscle more. This cycle ends in the heart losing the ability to maintain blood pressure, multi-organ failure, and death.

How quickly does systolic heart failure progress?

Without adequate treatment, ejection fraction in heart failure caused by blocked arteries or a heart attack can fall by 3–5 percentage points per year. On all four drug classes, progression often stabilizes or reverses. Each hospitalization for worsening fluid overload carries roughly 10% in-hospital mortality and accelerates the decline if hospitalizations keep recurring. Early treatment is far more effective than trying to catch up later.

Can you live a normal life with systolic heart failure?

Many patients with Stage C heart failure maintain minimal symptoms during normal daily activity on medication. There are real restrictions — watching sodium, taking multiple drugs daily, monitoring weight and symptoms. Competitive sport and heavy physical labor are usually not possible. But most people can work, travel, and stay active with good management. The difference between a well-managed and a poorly managed patient is significant — how consistently you take your medications is the biggest factor.

What is the difference between HFrEF and HFpEF?

HFrEF (EF below 40%): The heart squeeze is weak. Causes: heart attacks, blocked arteries, cardiomyopathy. Responds to the four drug classes in this article.

HFpEF (EF 50% or above): The squeeze is normal but the muscle is stiff and does not relax properly between beats. Causes: long-term high blood pressure, obesity, diabetes, aging. No drug class has a proven survival benefit yet.

HFmrEF (EF 41–49%): A borderline category. Evidence increasingly suggests these patients benefit from the same treatments used in HFrEF.

Do SGLT2 inhibitors work if you do not have diabetes?

Yes — and this is one of the most important heart failure discoveries of the last decade. Two large trials — EMPEROR-Reduced (empagliflozin) and DAPA-HF (dapagliflozin) — enrolled large numbers of patients without diabetes and found the same reduction in cardiovascular deaths and hospitalizations regardless of diabetes status. SGLT2 inhibitors are now recommended for all HFrEF patients with EF ≤ 40%, with or without diabetes.

Key Takeaways

What to Remember from This Article

Chronic systolic heart failure (HFrEF) means the heart’s main pumping chamber is too weak — ejection fraction falls below 40%

The three most common causes are blocked heart arteries, scarring from a previous heart attack, and an enlarged weakened heart (dilated cardiomyopathy)

Symptoms — breathlessness, leg swelling, fatigue, reduced exercise ability — come from both insufficient blood flow forward and fluid backing up into the lungs and body

Diagnosis is confirmed by echocardiogram; BNP/NT-proBNP blood tests track how well treatment is working

Four drug classes form the treatment core: ARNI/ACE inhibitor, beta-blocker (3 specific ones only), MRA, and SGLT2 inhibitor — all four should be started in most patients

Devices: ICD for EF ≤ 35% (prevents sudden cardiac death); CRT for EF ≤ 35% with left bundle branch block (improves pump efficiency)

Common co-existing conditions — atrial fibrillation, kidney disease, diabetes, iron deficiency — each require specific management adjustments

30–40% of patients with non-ischemic cardiomyopathy achieve EF recovery on full drug treatment

The two most impactful daily habits: weigh yourself every morning and keep sodium below 2,000 mg per day